Rauchfuss F, Utess F, Schüle S, Dittmar Y, Scheuerlein H, Settmacher U
Klinik für Allgemein-, Viszeral- und Gefäßchirurgie, Universitätsklinikum Jena, Erlanger Allee 101, 07747, Jena, Deutschland.
Chirurg. 2012 Mar;83(3):229-37. doi: 10.1007/s00104-011-2178-5.
Local non-resectable, hilar cholangiocarcinoma can be cured by performing a liver transplantation. The initially poor results after transplantation have significantly improved since neoadjuvant therapy protocols have been established. Therefore, hilar cholangiocarcinoma is now an accepted indication for liver transplantation in selected patients. This article summarizes the current state, recommendations and results of liver transplantation for these patients.
局部不可切除的肝门部胆管癌可通过肝移植治愈。自从建立了新辅助治疗方案以来,移植术后最初较差的结果有了显著改善。因此,肝门部胆管癌现在是部分患者肝移植的公认适应证。本文总结了这些患者肝移植的现状、建议和结果。